Safety and Pharmacokinetics Study of Human Monoclonal Antibody (AVP-21D9)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
Primary: • To compare the safety profile of a single intravenous administration of AVP-21D9 as compared with Placebo Secondary: * To evaluate the pharmacokinetics (PK) of a single intravenous administration of AVP-21D9 * To evaluate the immunogenicity of AVP-21D9
Epistemonikos ID: 9bcabd25cd20e7171a028099180259c9f879138a
First added on: May 05, 2024